{"id":286,"date":"2022-03-22T09:00:00","date_gmt":"2022-03-22T00:00:00","guid":{"rendered":"https:\/\/www.sonire-therapeutics.com\/?p=286"},"modified":"2025-11-25T19:39:16","modified_gmt":"2025-11-25T10:39:16","slug":"as-a-result-of-tohoku-israel-startup-global-challenge-program-tohru-satoh-president-ceo-of-sonire-therapeutics-inc-will-participate-in-a-panel-discussion-and-startup-pitch","status":"publish","type":"post","link":"https:\/\/www.sonire-therapeutics.com\/en\/as-a-result-of-tohoku-israel-startup-global-challenge-program-tohru-satoh-president-ceo-of-sonire-therapeutics-inc-will-participate-in-a-panel-discussion-and-startup-pitch\/","title":{"rendered":"As a result of Tohoku-Israel Startup Global Challenge Program, Tohru Satoh, President &#038; CEO of SONIRE Therapeutics Inc., will participate in a panel discussion and startup pitch."},"content":{"rendered":"\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link\" href=\"https:\/\/tohoku-israel.com\/English\" target=\"_blank\" rel=\"noreferrer noopener\">View More<\/a><\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_locale":"en_US","_original_post":"https:\/\/www.sonire-therapeutics.com\/?p=285","footnotes":""},"categories":[16],"tags":[],"class_list":["post-286","post","type-post","status-publish","format-standard","hentry","category-event","en-US"],"_links":{"self":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/comments?post=286"}],"version-history":[{"count":2,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/286\/revisions"}],"predecessor-version":[{"id":290,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/286\/revisions\/290"}],"wp:attachment":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/media?parent=286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/categories?post=286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/tags?post=286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}